


Healthcare Industry News: intradiscal ozone/oxygen
News Release - June 9, 2026
SpinaFX Medical receives FDA Investigational Device Exemption (IDE) for Triojection(R), its Breakthrough, Minimally-Invasive, Image-Guided Lumbar Disc Treatment
Source: SpinaFX Medical
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
